Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(52 sites)
United States
Xencor Investigative Site, Scottsdale, Arizona Xencor Investigative Site, Bradenton, Florida Xencor Investigative Site, Brandon, Florida Xencor Investigative Site, Jacksonville, Florida Xencor Investigative Site, Kissimmee, Florida